04:37 PM EST, 01/24/2025 (MT Newswires) -- Foghorn Therapeutics ( FHTX ) filed a registration statement with the US Securities and Exchange Commission Friday covering the potential sale of up to $300 million of securities in one or more offerings from time to time.

The filing covers common stock, preferred stock, warrants, and units, according to its prospectus. It plans to use the proceeds for general corporate purposes.